Mall G, Greber D, Gharenhbaghi H, Wiest G, Amann K, Mattfeldt T
Department of Pathology, University of Heidelberg, FRG.
Basic Res Cardiol. 1991;86 Suppl 3:33-44. doi: 10.1007/978-3-662-30769-4_4.
Light and electron microscopic stereological studies were performed on the myocardium of spontaneously hypertensive rats (SHR) before and after treatment with nifedipine (27 mg/kg b.w./day) and the sympatholytic agent moxonidine (8 mg/kg b.w./day). The treated groups were compared with nontreated SHR and normotensive WKY (n = 10 in each group). When the therapy was started in 6-month old male SHR, blood pressure was increased and left ventricular hypertrophy had developed. On the other hand, pathologic changes of myocardial structure were not observed. After 3 months, the nontreated hypertensive rats showed cardiac fibrosis (volume density of fibrosis + 45%), activation and proliferation of interstitial cells (volume density of nonvascular interstitium + 240%), media hypertrophy of small arteries (total volume of arterial media in the left ventricle + 180%), reduced capillarization (length density of capillaries--11%), as well as focal degeneration of myocytes at the ultrastructural level. Both treatments showed similar effects on blood pressure, degree of hypertrophy, and cardiac structure. Blood pressure as well as degree of hypertrophy were significantly reduced (relative left ventricular weights: --25% and --16%). As far as myocardial fibrosis, capillarization, and regressive changes of myocytes are concerned a complete normalization was observed. Microarteriopathy and activation of nonvascular interstitial cells (first step in development of interstitial myocardial fibrosis) were significantly suppressed by therapy (total media volume --40%, volume density of nonvascular interstitium --38%), but the normal level of the normotensive control could not be maintained (+ 70%, + 111% vs WKY). This may be due to the slightly elevated systolic blood pressure despite therapy (+ 25%, vs WKY) or to hormonal factors in SHR which are independent of blood pressure. Since nifedipine and moxonidine are pharmacologically different drugs with different effects on sympathetic activity, one may cautiously conclude that increase in blood pressure itself is an important determinant of arterial, interstitial as well as myocellular alterations which are related to the pathogenesis of hypertensive heart muscle disease.
对自发性高血压大鼠(SHR)在使用硝苯地平(27毫克/千克体重/天)和抗交感神经药莫索尼定(8毫克/千克体重/天)治疗前后的心肌进行了光镜和电镜体视学研究。将治疗组与未治疗的SHR和血压正常的WKY(每组n = 10)进行比较。当对6个月大的雄性SHR开始治疗时,血压升高且已出现左心室肥厚。另一方面,未观察到心肌结构的病理变化。3个月后,未治疗的高血压大鼠出现心脏纤维化(纤维化体积密度增加45%)、间质细胞活化和增殖(非血管间质体积密度增加240%)、小动脉中层肥厚(左心室动脉中层总体积增加180%)、毛细血管密度降低(毛细血管长度密度降低11%),以及超微结构水平上的心肌细胞局灶性变性。两种治疗对血压、肥厚程度和心脏结构均显示出相似的效果。血压以及肥厚程度均显著降低(相对左心室重量:分别降低25%和16%)。就心肌纤维化、毛细血管密度和心肌细胞退行性变化而言,观察到完全恢复正常。微动脉病变和非血管间质细胞活化(心肌间质纤维化发展的第一步)通过治疗得到显著抑制(中层总体积降低40%,非血管间质体积密度降低38%),但未能维持血压正常对照组的正常水平(与WKY相比分别增加70%、111%)。这可能是由于尽管治疗但收缩压仍略有升高(与WKY相比增加25%),或者是由于SHR中与血压无关的激素因素。由于硝苯地平和莫索尼定是药理作用不同、对交感神经活动影响不同的药物,因此可以谨慎地得出结论,血压升高本身是与高血压性心肌病发病机制相关的动脉、间质以及心肌细胞改变的重要决定因素。